{
    "eid": "2-s2.0-85067699416",
    "title": "Early pharmacokinetics of low dosage mycophenolate exposure in Thai kidney transplant recipients",
    "cover-date": "2019-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Toxicology",
            "@code": "3005",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Kidney transplantation",
        "Mycophenolate mofetil",
        "Mycophenolic acid",
        "Pharmacokinetics",
        "Renal function"
    ],
    "authors": [
        "Busaya Kulabusaya",
        "Somratai Vadcharavivad",
        "Yingyos Avihingsanon",
        "Teun van Gelder",
        "Kearkiat Praditpornsilpa"
    ],
    "citedby-count": 3,
    "ref-count": 38,
    "ref-list": [
        "Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial",
        "Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation",
        "Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation",
        "Therapeutic drug monitoring of mycophenolate mofetil in transplantation",
        "Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients",
        "Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation",
        "Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients",
        "Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms",
        "The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients",
        "Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil",
        "Population pharmacokinetics of mycophenolic acid in renal transplant recipients",
        "Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method",
        "The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials",
        "Model appropriateness and population pharmacokinetic modeling",
        "Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?",
        "Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period",
        "The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation",
        "Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant",
        "Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week",
        "Limited sampling strategy for predicting area under the concentration-time curve for mycophenolic Acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation",
        "Clinical pharmacokinetics of mycophenolate mofetil",
        "The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation",
        "Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients",
        "Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients",
        "Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid",
        "Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function",
        "Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable",
        "How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation",
        "KDIGO clinical practice guideline for the care of kidney transplant recipients",
        "Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German study group on mycophenolate mofetil therapy in pediatric renal transplant recipients",
        "Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia",
        "The effect of renal insufficiency on mycophenolic acid protein binding",
        "Pharmacokinetics of mycophenolic acid in renal insufficiency",
        "Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion",
        "The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy",
        "Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers",
        "Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study",
        "Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rotterdam",
            "@id": "60032114",
            "affilname": "Erasmus MC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032114",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Faculty of Pharmaceutical Sciences, Chulalongkorn University",
        "King Chulalongkorn Memorial Hospital"
    ]
}